Diplomat to dispense Takeda’s Ninlaro

FLINT, Mich. — Diplomat Pharmacy announced last week that it would be among the network of specialty pharmacies dispensing Takeda’s Ninlaro, a treatment for patients with multiple myeloma who have had prior therapy. 

The oral proteasome inhibitor works by blocking proteasomes, which are enzymes that help break down old or unwanted proteins. Blocking them makes a cancer cell’s survival more difficult by disrupting protein metabolism. 

“We are excited to offer patients the first oral proteasome inhibitor as an alternative treatment option for those with multiple myeloma,” Diplomat president Gary Kadlec said. “This breakthrough therapy will serve as an important treatment option for patients with unmet needs.”